After Treatment for Retinoblastoma

During treatment for retinoblastoma, the main concerns for most families are the daily aspects of getting through treatment and beating the cancer. After treatment, the concerns may shift toward the long-term effects of the cancer and its treatment, and concerns about the cancer still being there or coming back.

It is normal to want to put retinoblastoma and its treatment behind you and to get back to a life that does not revolve around cancer. But getting the right follow-up care offers your child the best chance for recovery and long-term survival.

Follow-up exams and tests

For several years after treatment, regular follow-up exams will be very important. The doctors will watch for any signs of the retinoblastoma coming back, as well as short-term and long-term side effects of treatment.

Once treatment is finished, your child's health care team will discuss a follow-up schedule with you, including which tests and exams should be done and how often. Each child will have a unique follow-up plan. It is very important to go to all follow-up appointments. Doctor visits and tests are usually done more often at first. If testing and exams are normal, the time between tests may then be extended.

What to expect during follow up

  • Eye exams are very important. Young children may need to be given medicine to sleep (general anesthesia) during the exam so the doctor can check their eyes carefully.
  • For children with heritable retinoblastoma, there is a small chance they could get a brain tumor (called trilateral or quadrilateral retinoblastoma). Regular MRI scans of the brain may be done for several years to check for this.

A benefit of follow-up care is that it gives you a chance to discuss questions and concerns that come up during and after your child’s recovery. For example, almost any cancer treatment can have side effects. Some might last only a short time, but others can last longer or might not show up until months or years later. It is important to report any new symptoms, such as pain or vision problems, to the doctor right away, so that the cause can be found and treated if needed.

Ask the cancer care team for a survivorship care plan

Talk with the treatment team about developing a survivorship care plan. This plan might include:

  • A summary of the diagnosis, tests done, and treatment given
  • A suggested schedule for follow-up exams and tests
  • A schedule for other tests that might be needed in the future, such as early detection (screening) tests for other types of cancer, or tests to look for other long-term health effects from the cancer or its treatment
  • A list of possible late or long-term side effects from treatment, including what to watch for and when to contact the doctor
  • Diet and physical activity suggestions

Staying prepared and organized

As much as you might want to put the experience behind you once treatment is done, it is very important be organized and stay on top of your child’s health. Gathering your child’s records soon after treatment may be easier than trying to get them at some point in the future.

Keep your child’s health insurance

It’s very important to keep your child’s health insurance. It can help cover the cost of follow-up visits, tests, and any care you may need in the future. No one wants to think about cancer coming back, but it’s best to be prepared.

Save your child's medical records

At some point, your child may see a new doctor who doesn’t know their cancer history. Keep copies of their medical records so you can easily share the details of their diagnosis and treatment when needed.

Late and long-term effects of treatment

Because of effective treatments, most children with retinoblastoma will live long lives. But some of the treatments needed to cure the cancer can affect a child’s health later in life. Watching for late effects of treatment as children age is a vital part of their long-term health care. The earlier problems are recognized, the more likely it is they can be treated.

Physical health after cancer treatment

Young people treated for retinoblastoma are at risk for several possible late effects of their treatment. This risk depends on a few factors, such as the stage and type of retinoblastoma and doses of treatment received. It is important to discuss what these health problems might be with your child’s medical team, so you know what to watch for.

Retinoblastoma tumors and many of the treatments used to treat them can impact a child’s ability to see.

For children who have enucleation, or an eye removed, the health and safety of the remaining eye is very important. Doctors often recommend children wear shatter-proof lenses (glasses) even if the vision is good in the remaining eye, to protect it from harm.

Local treatments, such as laser therapy, cryotherapy or chemo given directly to the eye through the ophthalmic artery or vitreous, may impact the ability to see as children age. Even if the risk of retinoblastoma returning is low, regular visits with an eye specialist are important to catch any signs of damage to the retina or other parts of the eye and treat them if needed.

For all survivors of retinoblastoma, regular eye exams are important. Make sure your eye doctor knows your medical history so they can make sure your eyes are as healthy as possible.

Radiation to the eye can change how the orbit (bones around the eye) grows and develops as a child gets older. Surgery can also affect how a child looks. A specialist, called an ocularist, can make prosthetics that look like a person’s natural eye. Prosthetics can help with self-image after treatment-related changes to the face. Such changes can also often be lessened by treatment in a center with expertise in reconstructive surgery. If needed, centers can also refer patients to special programs and facilities for the visually impaired.  Early intervention and counseling can also help address any psychological effects of changes in appearance.

Children who were treated for retinoblastoma may be at an increased risk of developing other cancers later in life.

A small risk of getting a blood cancer called leukemia later in life occurs in a small percentage of patients after getting certain chemo drugs, such as epipodophyllotoxins (etoposide), alkylating agents (cyclophosphamide), or anthracyclines (doxorubicin). The risk is higher in those children who get these drugs systemically, through the vein, compared to those who get the drugs locally to the eye.

Those children treated with radiation are also at an increased risk of second cancers in the treated area. External beam radiation therapy (EBRT) is given at higher doses than brachytherapy and carries a higher risk of second cancers than lower doses or local brachytherapy.

For children with the heritable form of retinoblastoma, where gene changes in RB1 are present through all the cells in the body, the risk of a second cancer is higher. Children and adults with heritable retinoblastoma have a higher risk of other cancers such as melanoma, osteosarcoma, and brain tumors. For more information, see Hereditary Retinoblastoma.

Chemo drugs like cisplatin and carboplatin can affect the kidneys. Regular kidney function testing may be recommended by your cancer care team to find and manage any kidney problems after treatment early on.

Children treated with platinum chemotherapy, such as cisplatin and carboplatin, are at an increased risk of developing hearing problems. A test called an audiogram may be done during and after treatment to assess any damage from chemo. Hearing is very important for young children in speech and social development. If hearing has been affected by chemotherapy, your cancer team may recommend seeing a hearing specialist, called an audiologist, to discuss hearing aids.

Some children can develop neuropathy, or damage to the nerves that control how the body moves and feels, after treatment with chemo drugs like vincristine. Symptoms of neuropathy, like numbness, tingling, or tripping while walking, often go away or get better once treatment is done. For some children, these symptoms may be lifelong.

Anthracycline (daunorubicin, doxorubicin) chemo drugs can cause heart problems later in life. For some survivors, echocardiograms to look at the strength of the heart muscle may be recommended to catch and treat problems early.

Alkylating chemo drugs (cyclophosphamide) may also affect sexual development and the ability to have children later in life. Talk to your child’s cancer care team about the risks of infertility with treatment, and ask if there are options for preserving fertility, such as sperm banking or egg freezing. For more information, see Preserving Fertility in Children and Teens With Cancer.

Emotional and social health in children and families affected by cancer

Once treatment is finished, a number of emotional concerns can come up. Some of these might occur many years after treatment and can include:

  • Dealing with physical changes that can result from the treatment
  • Worries about the cancer returning or new health problems developing
  • Feelings of resentment for having had cancer, having had to go through treatment, or having health problems when others do not
  • Feeling guilty for surviving cancer when other friends with cancer did not
  • Concerns about being treated differently or discriminated against (by friends, classmates, coworkers, employers, etc.)
  • Concerns about dating, marrying, and having a family later in life

It is normal to have some anxiety or other emotional reactions after treatment, but feeling overly worried, depressed, or angry can affect many aspects of a young person’s growth. It can get in the way of relationships, school, work, and other aspects of life. With support from family, friends, other survivors, mental health professionals, and others, many people who have survived cancer can thrive despite the challenges they have had to face.

Parents and other family members, especially siblings, can also be affected, both emotionally and in other ways. Some common family concerns include financial stresses, job loss or relationship stress during treatment, and worry about cancer returning. Social workers and other professionals at cancer centers can help families access help for these issues. Reach out to your child’s cancer center for help when needed.

To learn more about helping children with neuroblastoma and their loved ones cope during and after treatment, see Childhood Cancer.

Long-term follow-up guidelines

To help increase awareness of late effects and improve follow-up care of childhood cancer survivors throughout their lives, the Children’s Oncology Group (COG) has developed long-term follow-up guidelines for survivors of childhood cancers. These guidelines are used by your doctor to create a survivorship care plan specific to your child and their treatment. They can help you know what to watch for, what types of screening tests should be done to look for problems, and how late effects can be treated.

To learn more, ask your child’s doctors about the COG survivor guidelines. You can also read them on the COG website: www.survivorshipguidelines.org. The guidelines are written for health care professionals, but patient education on some late effects of treatment is available (as “Health Links”) on the site as well.

To learn more about some of the possible long-term effects of treatment, see Late Effects of Childhood Cancer Treatment.

side by side logos for American Cancer Society and American Society of Clinical Oncology

Developed by the American Cancer Society medical and editorial content team with medical review and contribution by the American Society of Clinical Oncology (ASCO).

Children’s Oncology Group. Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent and Young Adult Cancers, Version 6.0. Monrovia, CA: Children’s Oncology Group; 2023. Available on-line: www.survivorshipguidelines.org.

Leahey AM, Gombos DS, Chevez-Barrios P. Chapter 32: Retinoblastoma. In: Blaney SM, Adamson PC, Helman LJ, eds. Pizzo and Poplack’s Pediatric Oncology. 8th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2021.

National Cancer Institute. Retinoblastoma Treatment (PDQ®). 2025. Accessed at www.cancer.gov/types/retinoblastoma/hp/retinoblastoma-treatment-pdq on July 2, 2025.

Schonfeld SJ, Kleinerman RA, Abramson DH, Seddon JM, Tucker MA, Morton LM. Long-term risk of subsequent cancer incidence among hereditary and nonhereditary retinoblastoma survivors. Br J Cancer. 2021;124(7):1312-1319.

Tonorezos ES, Friedman DN, Barnea D, et al. Recommendations for Long-Term Follow-up of Adults with Heritable Retinoblastoma. Ophthalmology. 2020;127(11):1549-1557.

Last Revised: September 11, 2025

American Cancer Society Emails

Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.